Comparative risk of infections among JAK inhibitors used in rheumatoid arthritis: A network meta-analysis of clinical trials

被引：0
|
作者：
Alves, Carlos [1 ,2 ]
Mendes, Diogo [2 ]
Penedones, Ana [1 ,2 ]
Marques, Francisco Batel [1 ,2 ]
机构：
[1] Univ Coimbra, Sch Pharm, Coimbra, Portugal
[2] AIBILI Assoc Innovat & Biomed Res Light & Image, Coimbra, Portugal
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2020年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
4461
引用
收藏
页码：130 / 130
页数：1
相关论文
共 50 条
  • [21] Cardiovascular safety of the class of JAK inhibitors or tocilizumab compared with TNF inhibitors in patients with rheumatoid arthritis: Systematic review and a traditional and Bayesian network meta-analysis of randomized clinical trials
    Pugliesi, Alisson
    Chicre Oliveira, Daniela Gomes
    de Souza Filho, Vani Abreu
    Machado, Julia de Oliveira
    Pereira, Aline Gonsalves
    Silveira Bichuette, Julia de Castro
    Sachetto, Zoraida
    de Carvalho, Luiz Sergio F.
    Bertolo, Manoel Barros
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2024, 69
  • [22] Meta-analysis of serious infections with tofacitinib and biological treatment in rheumatoid arthritis clinical trials.
    Strand, Vibeke
    Ahadieh, Sima
    French, Jonathan
    Geier, Jamie
    Krishnaswami, Sriram
    Menon, Sujatha
    Checchio, Tina
    Boy, Mary
    Riese, Richard
    Gomez-Reino, Juan
    PHARMACOTHERAPY, 2014, 34 (10): : E224 - E224
  • [23] Authors’ Response to Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis
    Janet Pope
    Ruta Sawant
    Namita Tundia
    Ella X. Du
    Cynthia Z. Qi
    Yan Song
    Patrick Tang
    Keith A. Betts
    Advances in Therapy, 2021, 38 : 2750 - 2756
  • [24] Authors' Response to Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis
    Pope, Janet
    Sawant, Ruta
    Tundia, Namita
    Du, Ella X.
    Qi, Cynthia Z.
    Song, Yan
    Tang, Patrick
    Betts, Keith A.
    ADVANCES IN THERAPY, 2021, 38 (05) : 2750 - 2756
  • [25] The Comparative Safety of Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis: A Meta-analysis Update of 44 Trials
    Michaud, Tzeyu L.
    Rho, Young Hee
    Shamliyan, Tatyana
    Kuntz, Karen M.
    Choi, Hyon K.
    AMERICAN JOURNAL OF MEDICINE, 2014, 127 (12): : 1208 - 1232
  • [26] Efficacy of Janus Kinase (JAK) Inhibitors in Rheumatoid Arthritis: A Meta-analysis and Systematic Review
    Zhang, Tony
    Timmerman, Nicholas
    Lau, Arthur
    JOURNAL OF RHEUMATOLOGY, 2018, 45 (07) : 991 - 991
  • [27] The Risk of Adverse Effects of TNF-α Inhibitors in Patients With Rheumatoid Arthritis: A Network Meta-Analysis
    He, Bei
    Li, Yun
    Luo, Wen-wen
    Cheng, Xuan
    Xiang, Huai-rong
    Zhang, Qi-zhi
    He, Jie
    Peng, Wen-xing
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [28] Biologic Therapies in Rheumatoid Arthritis and the Risk of Opportunistic Infections: A Meta-analysis
    Kourbeti, Irene S.
    Ziakas, Panayiotis D.
    Mylonakis, Eleftherios
    CLINICAL INFECTIOUS DISEASES, 2014, 58 (12) : 1649 - 1657
  • [29] JAK inhibitors and the risk of infection: a meta-analysis
    Ran, Hao-Long
    Liu, Huan
    Xu, Wen-Ting
    Zhang, Jin-Rui
    Chen, Wei
    Dong, Han-Yue
    Li, Hongmin
    Tan, Cheng
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2025, 317 (01)
  • [30] Comparative Efficacy of Upadacitinib and Other Janus Kinase (JAK) Inhibitors in Patients With Moderate-to-Severe Rheumatoid Arthritis (RA): A Network Meta-analysis (NMA)
    Pope, Janet
    Sawant, Ruta
    Tundia, Namita
    Qi, Cynthia
    Betts, Keith
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (07) : 1153 - 1153
12345